Home
Scholarly Works
SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A...
Conference

SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A ANTIBODY PF-06480605 IN TREATMENT OF ULCERATIVE COLITIS: THE OPEN-LABEL, MULTICENTER, PHASE 2A TUSCANY STUDY

Authors

Danese S; Klopocka M; Scherl EJ; Romatowski JA; Allegretti JR; Peeva E; Vincent MS; Schoenbeck U; Xi L; Ye Z

Volume

158

Pagination

pp. S206-S207

Publisher

W B SAUNDERS CO-ELSEVIER INC

Publication Date

May 1, 2020

Name of conference

Crohn's and Colitis Congress

Conference place

TX, Austin

Conference start date

January 23, 2020

Conference end date

January 25, 2020

Conference proceedings

GASTROENTEROLOGY

Issue

6

ISSN

0016-5085

Contact the Experts team